ACAD Earnings

Quarterly EPS
$0.20
Q3 2024
$0.86
Q4 2024
$0.11
Q1 2025
$0.16
Q2 2025
$0.43
Q3 2025
$1.61
Q4 2025
$0.02
Q1 2026
$0.18
Q2 2026
Latest Revenue308.0M
Latest Net Income31.5M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.18308.0M31.5M+16.4%+12.5%
Q1 2026$0.02268.1M3.6M+9.7%-81.8%
Q4 2025$1.61284.0M273.6M+9.4%+87.2%
Q3 2025$0.43278.6M71.8M+11.3%+115.0%
Q2 2025$0.16264.6M26.7M+9.3%-20.0%
Q1 2025$0.11244.3M19.0M+18.7%+10.0%
Q4 2024$0.86259.6M143.7M+12.4%+207.1%
Q3 2024$0.20250.4M32.8M+18.3%+150.0%
Q2 2024$0.20242.0M33.4M
Q1 2024$0.10205.8M16.6M
Q4 2023$0.28231.0M45.8M
Q3 2023-$0.40211.7M-65176000
Acadia Pharmaceuticals (ACAD) — Earnings